€4.7B Irish R&D scheme threatens move

An Irish businessman's grand plan to build the world's largest R&D hub--the ambitiously titled Global Pharmaceutical Centre of Excellence--has attracted the avid interest of the country's many newspapers. And now backers are once again in the headlines with a threat to take their project and go to the North if local economic development officials don't deliver the support they'll need. At stake, backers claim, is a €4.7 billion project that could deliver some 4,500 jobs at a time many of the major pharma companies have been scaling back in the country. Story

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.